Traws Pharma (TRAW) Other Operating Expenses (2018 - 2026)
Traws Pharma (TRAW) posted quarterly Other Operating Expenses of -$583000.0 for Q1 2026, up 68.49% year-over-year from -$346021.8 in Q1 2025, and up 34.42% quarter-over-quarter from -$889000.0 in Q4 2025.
Traws Pharma (TRAW) Other Operating Expenses (2018 - 2026) Analysis & Trends
Traws Pharma (TRAW) has reported Other Operating Expenses for 4 consecutive years, with -$583000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Operating Expenses rose 68.49% year-over-year to -$583000.0; the TTM figure through Mar 2026 stood at -$2.5 million (down 102.23% YoY), while the FY2025 annual figure was -$2.6 million, down 102.27% from the prior year.
- Other Operating Expenses advanced to -$583000.0 in Q1 2026 per TRAW's latest filing, from -$889000.0 in the prior quarter.
- Across five years, Other Operating Expenses topped out at $116.6 million in Q2 2024 and bottomed at -$2.6 million in Q1 2024.
- Historically, Other Operating Expenses has averaged $12.0 million across 3 years, with a median of -$889000.0 in 2025.
- Annual changes were most pronounced in 2025 — Other Operating Expenses plunged 100.47% — and 2026, when it soared 68.49%.
- Traws Pharma's Other Operating Expenses stood at -$970000.0 in 2024, then gained by 8.35% to -$889000.0 in 2025, then soared by 34.42% to -$583000.0 in 2026.
- Business Quant data shows TRAW's Other Operating Expenses at -$583000.0 in Q1 2026, -$889000.0 in Q4 2025, and -$499000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Traws Pharma | 5.66 Mn | 639,491.99 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -583,000.00 |
| Dec 31, 2025 | -889,000.00 |
| Sep 30, 2025 | -499,000.00 |
| Jun 30, 2025 | -545,000.00 |
| Mar 31, 2025 | -1.85 Mn |
| Dec 31, 2024 | -970,000.00 |
| Sep 30, 2024 | -972,000.00 |
| Jun 30, 2024 | 116.61 Mn |
| Mar 31, 2024 | -2.58 Mn |
| Jun 30, 2018 | 693,000.00 |